ATRA - Company ID 0001604464
The table below shows Atara Biotherapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.22M | $8.36M | $5.74M | $16.90M | $13.84M | $46.45M |
| Short-term investments | $6.65M | - | $7.97M | $5.42M | $0.00 | $20.74M |
| Receivables | $318.00K | $0.00 | $1.91M | $0.00 | $8.88M | $1.33M |
| Inventory | - | - | $0.00 | $0.00 | $0.00 | $13.98M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $13.53M |
| $12.17M |
| $18.43M |
| $24.77M |
| $27.18M |
| $91.86M |
| Property, plant & equipment | $41.00K | $55.00K | $147.00K | $176.00K | $285.00K | $1.66M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $21.02M | $20.00M | $30.17M | $36.90M | $62.04M | $142.71M |
| Accounts payable | $824.00K | $637.00K | $318.00K | $1.76M | $1.38M | $2.15M |
| Total current liabilities | $6.85M | $5.64M | $18.06M | $14.56M | $47.89M | $155.98M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $58.02M | $57.31M | $66.80M | $71.94M | $117.11M | $233.25M |
| Retained earnings | -$2.03B | -$2.03B | -$2.02B | -$2.01B | -$2.02B | -$2.04B |
| Total equity | -$37.00M | -$37.31M | -$36.63M | -$35.04M | -$55.07M | -$90.54M |